Technology area: Biotechnology & Pharmaceuticals
10 pending office actions • 10 art units • 10 examiners • 0 of 10 (0%) have an AI response strategy ready • 14 patents granted in the last 365 days
Fudan University has 11 pending office actions in Biotechnology & Pharmaceuticals. Each matter is assigned to a distinct examiner and a distinct art unit, showing complete distribution across the supplied examination assignments.
WHITE, DAWANNA SHAR-DAY is the busiest examiner, with 1 pending office action. The absence of a recurring examiner concentration means counsel should organize strategy by application and art unit.
A central review can help maintain consistent scientific terminology and disclosure positions, while separate prosecution plans address the differing prior-art and examination records. The distributed structure also makes docket coordination important for preserving response quality across the portfolio.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 3 (30%) |
| §103 only | 1 (10%) |
| §112 only | 2 (20%) |
| Double-patenting + other | 2 (20%) |
| Multi-statute (no §101) | 2 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WHITE, DAWANNA SHAR-DAY | 1 | 62.4% | +24.3% |
| MEAH, MOHAMMAD Y | 1 | 70.7% | +42.8% |
| KRISHNAN, GANAPATHY | 1 | 52.7% | +1.3% |
| LIPPERT, JOHN WILLIAM | 1 | 59.2% | +39.9% |
| BAUER, BRIANNA LEE | 1 | 66.7% | +0.0% |
| MOUDOU, EILEEN QI-YUN | 1 | 50.0% | +0.0% |
| ALLEN, NICHOLAS E | 1 | 75.6% | +14.6% |
| KATAKAM, SUDHAKAR | 1 | 74.8% | +23.3% |
| SAWYER, JENNIFER C | 1 | 68.4% | -8.2% |
| WANG, CHANG YU | 1 | 33.4% | +53.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18520221 | DATA SEARCH METHOD AND APPARATUS, AND DEVICE | ALLEN, NICHOLAS E | 21d |
| 18817861 | SUSTAINED-RELEASE GEL WITH INSOLUBLE SALT AS PH ADJUSTER, PREPARATION METHOD AND APPLICATION THEREOF | KRISHNAN, GANAPATHY | — |
| 18717525 | SMALL MOLECULE TRACERS BINDING TO ALPHA-SYNUCLEIN AGGREGATES AND THEIR USES | LIPPERT, JOHN WILLIAM | — |
| 18707314 | COMPOUNDS HAVING ACTIVITY OF DEGRADING GSPT1 AND APPLICATION THEREOF | BAUER, BRIANNA LEE | — |
| 18276365 | TOTAL SYNTHESIS METHOD FOR VITAMIN A AND DERIVATIVE THEREOF AND DEUTERATED COMPOUND THEREOF | SAWYER, JENNIFER C | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18520221 | DATA SEARCH METHOD AND APPARATUS, AND DEVICE | ALLEN, NICHOLAS E | 21d |
| 18992842 | RETINOIC ACID-ALCOHOL AMINE COMPLEX, PREPARATION METHOD AND APPLICATION THEREOF | WHITE, DAWANNA SHAR-DAY | — |
| 18885576 | Three-dimensional model of exposed microbial membranes at gas-liquid interface and preparation method thereof | MEAH, MOHAMMAD Y | — |
| 18717525 | SMALL MOLECULE TRACERS BINDING TO ALPHA-SYNUCLEIN AGGREGATES AND THEIR USES | LIPPERT, JOHN WILLIAM | — |
| 18550862 | BECLIN 1-TARGETED STAPLED PEPTIDE AND PHARMACEUTICAL COMPOSITION | KATAKAM, SUDHAKAR | — |
| 17437968 | METHOD FOR SCREENING COMPOUND FOR TREATING OR PREVENTING POLYQ-RELATED NEURODEGENERATIVE DISEASES | WANG, CHANG YU | — |
| Art Unit | Apps |
|---|---|
| 1627 | 1 |
| 1652 | 1 |
| 1693 | 1 |
| 1615 | 1 |
| 1623 | 1 |
| 1738 | 1 |
| 2154 | 1 |
| 1658 | 1 |
| 1691 | 1 |
| 1675 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18992842 | RETINOIC ACID-ALCOHOL AMINE COMPLEX, PREPARATION METHOD AND APPLICATION THEREOF | WHITE, DAWANNA SHAR-DAY | 1627 | §103§112DP | Non-Final OA | — | Pending | Jan 09, 2025 |
| 18885576 | Three-dimensional model of exposed microbial membranes at gas-liquid interface and preparation method thereof | MEAH, MOHAMMAD Y | 1652 | §112 | Non-Final OA | — | Pending | Sep 14, 2024 |
| 18817861 | SUSTAINED-RELEASE GEL WITH INSOLUBLE SALT AS PH ADJUSTER, PREPARATION METHOD AND APPLICATION THEREOF | KRISHNAN, GANAPATHY | 1693 | §101§102§103§112 | Non-Final OA | — | Pending | Aug 28, 2024 |
| 18717525 | SMALL MOLECULE TRACERS BINDING TO ALPHA-SYNUCLEIN AGGREGATES AND THEIR USES | LIPPERT, JOHN WILLIAM | 1615 | §103§112 | Non-Final OA | — | Pending | Jun 07, 2024 |
| 18707314 | COMPOUNDS HAVING ACTIVITY OF DEGRADING GSPT1 AND APPLICATION THEREOF | BAUER, BRIANNA LEE | 1623 | §102§103§112 | Non-Final OA | — | Pending | May 03, 2024 |
| 18625907 | DEVICE AND METHOD FOR ON-LINE CONTINUOUS RECOVERY OF EXCESS NITRIC ACID IN NITRATION REACTION | MOUDOU, EILEEN QI-YUN | 1738 | §103 | Non-Final OA | — | Pending | Apr 03, 2024 |
| 18520221 | DATA SEARCH METHOD AND APPARATUS, AND DEVICE | ALLEN, NICHOLAS E | 2154 | §101§103§112 | Final Rejection | 21d | Pending | Nov 27, 2023 |
| 18550862 | BECLIN 1-TARGETED STAPLED PEPTIDE AND PHARMACEUTICAL COMPOSITION | KATAKAM, SUDHAKAR | 1658 | §103§112DP | Final Rejection | — | Pending | Sep 15, 2023 |
| 18276365 | TOTAL SYNTHESIS METHOD FOR VITAMIN A AND DERIVATIVE THEREOF AND DEUTERATED COMPOUND THEREOF | SAWYER, JENNIFER C | 1691 | §101§112 | Non-Final OA | — | Pending | Aug 08, 2023 |
| 17437968 | METHOD FOR SCREENING COMPOUND FOR TREATING OR PREVENTING POLYQ-RELATED NEURODEGENERATIVE DISEASES | WANG, CHANG YU | 1675 | §112 | Non-Final OA | — | Pending | Sep 10, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialFudan University has 10 pending office actions as of October 2026, spread across 10 art units and 10 examiners.
Dawanna Shar-Day White has the most, with 1 of Fudan University's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
